In the last 12 months, insiders at NovoCure Ltd ($NVCR) filed 328 transactions with the SEC: 4 open-market purchases totaling $1,228,659 and 133 sales totaling $40,025,802. Net insider sentiment: net selling.
NovoCure Ltd operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Danziger Asaf (Chief Executive Officer) — 17 transactions totaling $24,763,898
- Leonard Frank X (President, CNS Cancers US) — 31 transactions totaling $6,666,158
- GROENHUYSEN WILHELMUS CM (Chief Operating Officer) — 21 transactions totaling $5,942,932
- Ben Arye Barak (General Counsel) — 16 transactions totaling $4,661,557
- Cordova Ashley (Chief Executive Officer) — 12 transactions totaling $4,335,272
View all SEC Filings for NovoCure Ltd (NVCR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | S | Ordinary Shares | 21330 | $13.43 | 328,397.0000 | 111,981,981 | 6.10% | 0.02% |
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | A | Stock Option (Right to Buy) | 258445 | $0.00 | 258,445.0000 | 111,981,981 | 9999.99% | 0.23% |
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | A | Stock Option (Right to Buy) | 30072 | $0.00 | 288,517.0000 | 111,981,981 | 11.64% | 0.03% |
| March 4, 2026 | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 17638 | $13.30 | 422,570.0000 | 111,981,981 | 4.01% | 0.02% |
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | S | Ordinary Shares | 50557 | $12.79 | 349,727.0000 | 111,981,981 | 12.63% | 0.05% |
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | A | Ordinary Shares | 200284 | $0.00 | 400,284.0000 | 111,981,981 | 100.14% | 0.18% |
| March 3, 2026 | DOYLE WILLIAM F | Executive Chairman | A | Ordinary Shares | 200000 | $0.00 | 200,000.0000 | 111,981,981 | 9999.99% | 0.18% |
| March 3, 2026 | Puri Michal Nath | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 58672 | $0.00 | 58,672.0000 | 111,981,981 | 9999.99% | 0.05% |
| March 4, 2026 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 1100 | $13.31 | 201,322.0000 | 111,981,981 | 0.54% | 0.00% |
| March 3, 2026 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 40100 | $0.00 | 202,422.0000 | 111,981,981 | 24.70% | 0.04% |
| March 3, 2026 | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 58488 | $0.00 | 66,006.0000 | 111,981,981 | 777.97% | 0.05% |
| March 3, 2026 | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 7518 | $0.00 | 7,518.0000 | 111,981,981 | 9999.99% | 0.01% |
| March 5, 2026 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 43246 | $13.77 | 72,832.0000 | 111,981,981 | 37.26% | 0.04% |
| March 4, 2026 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 5377 | $13.31 | 116,078.0000 | 111,981,981 | 4.43% | 0.00% |
| March 3, 2026 | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 45112 | $0.00 | 121,455.0000 | 111,981,981 | 59.09% | 0.04% |
| March 3, 2026 | Leonard Frank X | Chief Executive Officer | A | Stock Option (Right to Buy) | 216388 | $0.00 | 216,388.0000 | 111,981,981 | 9999.99% | 0.19% |
| March 4, 2026 | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 5607 | $13.31 | 493,793.0000 | 111,981,981 | 1.12% | 0.01% |
| March 3, 2026 | Leonard Frank X | Chief Executive Officer | A | Ordinary Shares | 150000 | $0.00 | 499,400.0000 | 111,981,981 | 42.93% | 0.13% |
| March 3, 2026 | Brackmann Christoph | Chief Financial Officer | A | Stock Option (Right to Buy) | 80674 | $0.00 | 80,674.0000 | 111,981,981 | 9999.99% | 0.07% |
| March 4, 2026 | Brackmann Christoph | Chief Financial Officer | S | Ordinary Shares | 6412 | $13.31 | 182,842.0000 | 111,981,981 | 3.39% | 0.01% |
| March 3, 2026 | Brackmann Christoph | Chief Financial Officer | A | Ordinary Shares | 55137 | $0.00 | 189,254.0000 | 111,981,981 | 41.11% | 0.05% |
| March 3, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | A | Stock Option (Right to Buy) | 73340 | $0.00 | 73,340.0000 | 111,981,981 | 9999.99% | 0.07% |
| March 4, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 6412 | $13.31 | 267,190.0000 | 111,981,981 | 2.34% | 0.01% |
| March 3, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | A | Ordinary Shares | 50125 | $0.00 | 273,602.0000 | 111,981,981 | 22.43% | 0.04% |
| March 3, 2026 | Ben Arye Barak | General Counsel | A | Stock Option (Right to Buy) | 73340 | $0.00 | 73,340.0000 | 111,981,981 | 9999.99% | 0.07% |
| March 3, 2026 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 50125 | $0.00 | 242,453.0000 | 111,981,981 | 26.06% | 0.04% |
| March 4, 2026 | Leupin Nicolas | Former Chief Medical Officer | S | Ordinary Shares | 1100 | $13.31 | 102,979.0000 | 111,981,981 | 1.06% | 0.00% |
| March 2, 2026 | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 7232 | $13.49 | 349,400.0000 | 111,981,981 | 2.03% | 0.01% |
| Feb. 27, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 7461 | $13.84 | 213,757.0000 | 111,981,981 | 3.37% | 0.01% |
| Feb. 28, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | A | Ordinary Shares | 12992 | $0.00 | 226,749.0000 | 111,981,981 | 6.08% | 0.01% |
| March 2, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 3272 | $13.33 | 223,477.0000 | 111,981,981 | 1.44% | 0.00% |
| Feb. 27, 2026 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 1441 | $13.66 | 162,322.0000 | 111,981,981 | 0.88% | 0.00% |
| Feb. 27, 2026 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1555 | $13.66 | 76,751.0000 | 111,981,981 | 1.99% | 0.00% |
| March 2, 2026 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 408 | $13.49 | 76,343.0000 | 111,981,981 | 0.53% | 0.00% |
| Feb. 27, 2026 | Leupin Nicolas | Former Chief Medical Officer | S | Ordinary Shares | 1029 | $13.66 | 104,079.0000 | 111,981,981 | 0.98% | 0.00% |
| Feb. 27, 2026 | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 9734 | $13.66 | 338,011.0000 | 111,981,981 | 2.80% | 0.01% |
| Feb. 28, 2026 | Leonard Frank X | Chief Executive Officer | A | Ordinary Shares | 18621 | $0.00 | 356,632.0000 | 111,981,981 | 5.51% | 0.02% |
| Feb. 27, 2026 | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 11541 | $13.75 | 426,028.0000 | 111,981,981 | 2.64% | 0.01% |
| Feb. 28, 2026 | Cordova Ashley | Former Chief Executive Officer | A | Ordinary Shares | 23818 | $0.00 | 449,846.0000 | 111,981,981 | 5.59% | 0.02% |
| March 2, 2026 | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 2410 | $13.67 | 447,436.0000 | 111,981,981 | 0.54% | 0.00% |
| March 2, 2026 | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 7228 | $13.67 | 440,208.0000 | 111,981,981 | 1.62% | 0.01% |
| Feb. 28, 2026 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 17755 | $0.00 | 192,328.0000 | 111,981,981 | 10.17% | 0.02% |
| Jan. 11, 2026 | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 2133 | $14.35 | 78,306.0000 | 111,981,981 | 2.65% | 0.00% |
| Dec. 31, 2025 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 108 | $10.99 | 174,573.0000 | 111,981,981 | 0.06% | 0.00% |
| Dec. 31, 2025 | Danziger Asaf | Not found | A | Ordinary Shares | 1 | $10.99 | 416,474.0000 | 111,981,981 | 0.00% | 0.00% |
| Dec. 31, 2025 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 1 | $10.99 | 163,763.0000 | 111,981,981 | 0.00% | 0.00% |
| Nov. 1, 2025 | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 168 | $12.81 | 83,388.0000 | 111,981,981 | 0.20% | 0.00% |
| Nov. 1, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | F | Ordinary Shares | 966 | $12.81 | 347,745.0000 | 111,981,981 | 0.28% | 0.00% |
| Oct. 31, 2025 | Puri Michal Nath | Chief Human Resources Officer | F | Ordinary Shares | 752 | $12.82 | 163,762.0000 | 111,981,981 | 0.46% | 0.00% |
| Nov. 4, 2025 | Brackmann Christoph | Chief Financial Officer | F | Ordinary Shares | 7033 | $12.23 | 134,117.0000 | 111,981,981 | 4.98% | 0.01% |
| Nov. 4, 2025 | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 2949 | $12.23 | 80,439.0000 | 111,981,981 | 3.54% | 0.00% |
| Sept. 5, 2025 | Cordova Ashley | Chief Executive Officer | P | Ordinary Shares | 81550 | $12.22 | 437,569.0000 | 109,915,429 | 22.91% | 0.07% |
| July 29, 2025 | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 5000 | $11.50 | 141,150.0000 | 109,915,429 | 3.67% | 0.00% |
| July 29, 2025 | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 10000 | $11.63 | 131,150.0000 | 109,915,429 | 8.25% | 0.01% |
| July 29, 2025 | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 5000 | $11.60 | 136,150.0000 | 109,915,429 | 3.81% | 0.00% |
| June 30, 2025 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 769 | $15.13 | 174,465.0000 | 109,915,429 | 0.44% | 0.00% |
| June 30, 2025 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 833 | $15.13 | 164,514.0000 | 109,915,429 | 0.51% | 0.00% |
| June 30, 2025 | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 833 | $15.13 | 356,019.0000 | 109,915,429 | 0.23% | 0.00% |
| June 30, 2025 | Danziger Asaf | Not found | A | Ordinary Shares | 833 | $15.13 | 416,473.0000 | 109,915,429 | 0.20% | 0.00% |
| June 30, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 833 | $15.13 | 348,711.0000 | 109,915,429 | 0.24% | 0.00% |
| June 4, 2025 | HILLEMAN JERYL L | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | Madden Martin J. | Not found | A | Stock Option (Right to Buy) | 33393 | $0.00 | 33,393.0000 | 109,915,429 | 9999.99% | 0.03% |
| June 4, 2025 | Stafford Kristin | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 179426 | $0.00 | 347,878.0000 | 109,915,429 | 106.51% | 0.16% |
| June 4, 2025 | VERNON W ANTHONY | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | VERNON W ANTHONY | Not found | A | Ordinary Shares | 11215 | $0.00 | 179,102.0000 | 109,915,429 | 6.68% | 0.01% |
| June 4, 2025 | Hung David | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | Hung David | Not found | A | Ordinary Shares | 11215 | $0.00 | 23,410.0000 | 109,915,429 | 91.96% | 0.01% |
| June 4, 2025 | Scannell Timothy J | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | LEUNG GABRIEL | Not found | A | Ordinary Shares | 11215 | $0.00 | 92,444.0000 | 109,915,429 | 13.81% | 0.01% |
| June 4, 2025 | LEUNG GABRIEL | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | Stafford Kristin | Not found | A | Ordinary Shares | 11215 | $0.00 | 14,269.0000 | 109,915,429 | 367.22% | 0.01% |
| June 4, 2025 | Scannell Timothy J | Not found | A | Ordinary Shares | 11215 | $0.00 | 17,233.0000 | 109,915,429 | 186.36% | 0.01% |
| June 4, 2025 | Ocean Allyson J | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 4, 2025 | Ocean Allyson J | Not found | A | Ordinary Shares | 11215 | $0.00 | 14,269.0000 | 109,915,429 | 367.22% | 0.01% |
| June 4, 2025 | HILLEMAN JERYL L | Not found | A | Ordinary Shares | 11215 | $0.00 | 16,806.0000 | 109,915,429 | 200.59% | 0.01% |
| June 3, 2025 | Ocean Allyson J | Not found | S | Ordinary Shares | 999 | $17.29 | 3,054.0000 | 109,915,429 | 24.65% | 0.00% |
| June 3, 2025 | Stafford Kristin | Not found | S | Ordinary Shares | 999 | $17.28 | 3,054.0000 | 109,915,429 | 24.65% | 0.00% |
| June 3, 2025 | LEUNG GABRIEL | Not found | S | Ordinary Shares | 999 | $17.31 | 81,229.0000 | 109,915,429 | 1.21% | 0.00% |
| June 3, 2025 | Madden Martin J. | Not found | S | Ordinary Shares | 999 | $17.19 | 18,674.0000 | 109,915,429 | 5.08% | 0.00% |
| June 3, 2025 | Scannell Timothy J | Not found | S | Ordinary Shares | 999 | $17.32 | 6,018.0000 | 109,915,429 | 14.24% | 0.00% |
| June 3, 2025 | HILLEMAN JERYL L | Not found | S | Ordinary Shares | 999 | $17.26 | 5,591.0000 | 109,915,429 | 15.16% | 0.00% |
| June 3, 2025 | VERNON W ANTHONY | Not found | S | Ordinary Shares | 999 | $17.35 | 167,887.0000 | 109,915,429 | 0.59% | 0.00% |
| June 3, 2025 | Hung David | Not found | S | Ordinary Shares | 999 | $17.30 | 12,195.0000 | 109,915,429 | 7.57% | 0.00% |
| June 2, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 21717 | $17.22 | 176,931.0000 | 109,915,429 | 10.93% | 0.02% |
| June 2, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 6600 | $17.99 | 170,331.0000 | 109,915,429 | 3.73% | 0.01% |
| June 2, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1879 | $19.01 | 168,452.0000 | 109,915,429 | 1.10% | 0.00% |
| May 3, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 592 | $17.91 | 83,556.0000 | 109,915,429 | 0.70% | 0.00% |
| March 4, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 54975 | $18.19 | 198,648.0000 | 109,915,429 | 38.26% | 0.05% |
| March 4, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 54975 | $18.19 | 84,148.0000 | 109,915,429 | 188.44% | 0.05% |
| March 4, 2025 | Paravasthu Mukund | Chief Operating Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 151181 | $18.19 | 355,186.0000 | 109,915,429 | 74.11% | 0.14% |
| March 4, 2025 | Cordova Ashley | Chief Executive Officer | A | Stock Options (Right to buy) | 224123 | $18.19 | 224,123.0000 | 109,915,429 | 9999.99% | 0.20% |
| March 4, 2025 | Weinberg Uri | Chief Innovation Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Leupin Nicolas | Chief Medical Officer | A | Ordinary Shares | 54975 | $18.19 | 105,108.0000 | 109,915,429 | 109.66% | 0.05% |
| March 4, 2025 | Leupin Nicolas | Chief Medical Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 54975 | $18.19 | 173,696.0000 | 109,915,429 | 46.31% | 0.05% |
| March 4, 2025 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 54975 | $18.19 | 221,218.0000 | 109,915,429 | 33.07% | 0.05% |
| March 4, 2025 | Ben Arye Barak | General Counsel | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 54975 | $18.19 | 163,681.0000 | 109,915,429 | 50.57% | 0.05% |
| March 4, 2025 | Puri Michal Nath | Chief Human Resources Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | Brackmann Christoph | Chief Financial Officer | A | Ordinary Shares | 54975 | $18.19 | 121,150.0000 | 109,915,429 | 83.08% | 0.05% |
| March 4, 2025 | Brackmann Christoph | Chief Financial Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 3, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2527 | $18.54 | 143,673.0000 | 109,915,429 | 1.73% | 0.00% |
| March 3, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2053 | $18.54 | 204,005.0000 | 109,915,429 | 1.00% | 0.00% |
| March 3, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 250 | $18.54 | 29,173.0000 | 109,915,429 | 0.85% | 0.00% |
| March 3, 2025 | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 268 | $18.92 | 166,243.0000 | 109,915,429 | 0.16% | 0.00% |
| Feb. 27, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 1808 | $20.55 | 208,399.0000 | 109,915,429 | 0.86% | 0.00% |
| Feb. 27, 2025 | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 830 | $19.92 | 50,294.0000 | 109,915,429 | 1.62% | 0.00% |
| Feb. 27, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 267 | $20.55 | 29,791.0000 | 109,915,429 | 0.89% | 0.00% |
| Feb. 28, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 368 | $18.28 | 29,423.0000 | 109,915,429 | 1.24% | 0.00% |
| Feb. 27, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 267 | $20.55 | 29,791.0000 | 109,915,429 | 0.89% | 0.00% |
| Feb. 27, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1379 | $19.92 | 30,058.0000 | 109,915,429 | 4.39% | 0.00% |
| Feb. 28, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2341 | $18.28 | 206,058.0000 | 109,915,429 | 1.12% | 0.00% |
| Feb. 27, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 1808 | $20.55 | 208,399.0000 | 109,915,429 | 0.86% | 0.00% |
| Feb. 27, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 9345 | $19.92 | 210,207.0000 | 109,915,429 | 4.26% | 0.01% |
| Feb. 28, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2770 | $18.28 | 146,200.0000 | 109,915,429 | 1.86% | 0.00% |
| Feb. 27, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1989 | $20.55 | 148,970.0000 | 109,915,429 | 1.32% | 0.00% |
| Feb. 27, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 10277 | $19.92 | 150,959.0000 | 109,915,429 | 6.37% | 0.01% |
| Feb. 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 225 | $20.55 | 108,706.0000 | 109,915,429 | 0.21% | 0.00% |
| Feb. 28, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 368 | $18.28 | 29,423.0000 | 109,915,429 | 1.24% | 0.00% |
| Feb. 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 1162 | $19.92 | 108,931.0000 | 109,915,429 | 1.06% | 0.00% |
| Feb. 27, 2025 | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 161 | $20.55 | 50,133.0000 | 109,915,429 | 0.32% | 0.00% |
| Feb. 27, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1379 | $19.92 | 30,058.0000 | 109,915,429 | 4.39% | 0.00% |
| Feb. 28, 2025 | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 311 | $18.31 | 166,511.0000 | 109,915,429 | 0.19% | 0.00% |
| Feb. 28, 2025 | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 4326 | $18.78 | 166,822.0000 | 109,915,429 | 2.53% | 0.00% |
| Feb. 28, 2025 | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 4326 | $18.78 | 166,822.0000 | 109,915,429 | 2.53% | 0.00% |
| Feb. 28, 2025 | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 311 | $18.31 | 166,511.0000 | 109,915,429 | 0.19% | 0.00% |
| Feb. 27, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 9345 | $19.92 | 210,207.0000 | 109,915,429 | 4.26% | 0.01% |
| Feb. 28, 2025 | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2341 | $18.28 | 206,058.0000 | 109,915,429 | 1.12% | 0.00% |
| Feb. 27, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 10277 | $19.92 | 150,959.0000 | 109,915,429 | 6.37% | 0.01% |
| Feb. 27, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1989 | $20.55 | 148,970.0000 | 109,915,429 | 1.32% | 0.00% |
| Feb. 28, 2025 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2770 | $18.28 | 146,200.0000 | 109,915,429 | 1.86% | 0.00% |
| Feb. 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 1162 | $19.92 | 108,931.0000 | 109,915,429 | 1.06% | 0.00% |
| Feb. 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 225 | $20.55 | 108,706.0000 | 109,915,429 | 0.21% | 0.00% |
| Feb. 27, 2025 | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 830 | $19.92 | 50,294.0000 | 109,915,429 | 1.62% | 0.00% |
| Feb. 27, 2025 | Leupin Nicolas | Chief Medical Officer | S | Ordinary Shares | 161 | $20.55 | 50,133.0000 | 109,915,429 | 0.32% | 0.00% |
| Jan. 11, 2025 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 2160 | $26.81 | 31,437.0000 | 0 | 6.43% | 0.00% |
| Dec. 31, 2024 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 669 | $14.75 | 118,721.0000 | 0 | 0.57% | 0.00% |
| Dec. 31, 2024 | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 373 | $14.75 | 219,552.0000 | 0 | 0.17% | 0.00% |
| Jan. 1, 2025 | Danziger Asaf | Not found | A | Ordinary Shares | 400000 | $0.00 | 415,640.0000 | 0 | 2557.55% | 0.00% |
| Dec. 31, 2024 | Danziger Asaf | Not found | A | Ordinary Shares | 412 | $14.75 | 15,640.0000 | 0 | 2.71% | 0.00% |
| Nov. 2, 2024 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 44 | $16.69 | 3,459.0000 | 0 | 1.26% | 0.00% |
| Nov. 4, 2024 | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 45620 | $16.59 | 45,620.0000 | 0 | 9999.99% | 0.00% |
| Nov. 4, 2024 | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 30138 | $0.00 | 33,597.0000 | 0 | 871.29% | 0.00% |
| Oct. 31, 2024 | Puri Michal Nath | Chief Human Resources Officer | S | Ordinary Shares | 810 | $15.79 | 110,093.0000 | 0 | 0.73% | 0.00% |
| Nov. 1, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 598 | $15.94 | 161,236.0000 | 0 | 0.37% | 0.00% |
| Nov. 1, 2024 | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 160 | $15.88 | 3,503.0000 | 0 | 4.37% | 0.00% |
| June 28, 2024 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 930 | $12.24 | 118,052.0000 | 0 | 0.79% | 0.00% |
| June 28, 2024 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 1286 | $12.24 | 220,465.0000 | 0 | 0.59% | 0.00% |
| June 28, 2024 | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 1239 | $12.24 | 15,228.0000 | 0 | 8.86% | 0.00% |
| June 28, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 1055 | $12.24 | 252,290.0000 | 0 | 0.42% | 0.00% |
| June 28, 2024 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 1736 | $12.24 | 110,903.0000 | 0 | 1.59% | 0.00% |
| June 28, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 1736 | $12.24 | 161,834.0000 | 0 | 1.08% | 0.00% |
| Aug. 2, 2024 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 688 | $20.14 | 219,179.0000 | 0 | 0.31% | 0.00% |
| June 5, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M | Ordinary Shares | 124373 | $22.82 | 375,608.0000 | 0 | 49.50% | 0.00% |
| June 5, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M | Stock Options (Right to buy) | 124373 | $22.82 | 95,000.0000 | 0 | 56.69% | 0.00% |
| June 5, 2024 | Ocean Allyson J | Not found | A | Restricted Stock Units | 4053 | $0.00 | 4,053.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | VERNON W ANTHONY | Not found | S | Ordinary Shares | 964 | $23.89 | 164,833.0000 | 0 | 0.58% | 0.00% |
| June 5, 2024 | VERNON W ANTHONY | Not found | A | Restricted Stock Units | 4053 | $0.00 | 169,850.0000 | 0 | 2.44% | 0.00% |
| June 5, 2024 | VERNON W ANTHONY | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Scannell Timothy J | Not found | S | Ordinary Shares | 964 | $23.89 | 2,964.0000 | 0 | 24.54% | 0.00% |
| June 5, 2024 | Scannell Timothy J | Not found | A | Restricted Stock Units | 4053 | $0.00 | 7,981.0000 | 0 | 103.18% | 0.00% |
| June 5, 2024 | Scannell Timothy J | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | LEUNG GABRIEL | Not found | S | Ordinary Shares | 964 | $23.89 | 78,175.0000 | 0 | 1.22% | 0.00% |
| June 5, 2024 | LEUNG GABRIEL | Not found | A | Restricted Stock Units | 4053 | $0.00 | 83,192.0000 | 0 | 5.12% | 0.00% |
| June 5, 2024 | LEUNG GABRIEL | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | HILLEMAN JERYL L | Not found | A | Restricted Stock Units | 4053 | $0.00 | 6,590.0000 | 0 | 159.76% | 0.00% |
| June 5, 2024 | HILLEMAN JERYL L | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Stafford Kristin | Not found | A | Ordinary Shares | 4053 | $0.00 | 4,053.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Hung David | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Hung David | Not found | A | Restricted Stock Units | 4053 | $0.00 | 13,194.0000 | 0 | 44.34% | 0.00% |
| June 5, 2024 | Madden Martin J. | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Madden Martin J. | Not found | A | Ordinary Shares | 4053 | $0.00 | 19,673.0000 | 0 | 25.95% | 0.00% |
| June 5, 2024 | Ocean Allyson J | Not found | A | Stock Options (Right to buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Stafford Kristin | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1679 | $16.03 | 160,938.0000 | 0 | 1.03% | 0.00% |
| March 4, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1217 | $16.01 | 251,235.0000 | 0 | 0.48% | 0.00% |
| March 4, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 840 | $16.01 | 160,098.0000 | 0 | 0.52% | 0.00% |
| March 1, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2107 | $16.03 | 252,452.0000 | 0 | 0.83% | 0.00% |
| Feb. 27, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 47034 | $16.30 | 256,862.0000 | 0 | 22.42% | 0.00% |
| Feb. 28, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2078 | $16.14 | 162,617.0000 | 0 | 1.26% | 0.00% |
| Feb. 27, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Stock Options (Right to buy) | 156348 | $16.30 | 156,348.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 71574 | $16.30 | 109,167.0000 | 0 | 190.39% | 0.00% |
| Feb. 27, 2024 | Puri Michal Nath | Chief Human Resources Officer | A | Stock Options (Right to buy) | 109443 | $16.30 | 109,443.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 81799 | $16.30 | 171,148.0000 | 0 | 91.55% | 0.00% |
| Feb. 27, 2024 | Weinberg Uri | Chief Innovation Officer | A | Stock Options (Right to buy) | 125078 | $16.30 | 125,078.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Leupin Nicolas | Chief Medical Officer | A | Ordinary Shares | 51124 | $16.30 | 51,124.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Leupin Nicolas | Chief Medical Officer | A | Stock Options (Right to buy) | 78174 | $16.30 | 78,174.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Giladi Moshe | Chief Science Officer | A | Ordinary Shares | 51124 | $16.30 | 69,771.0000 | 0 | 274.17% | 0.00% |
| Feb. 27, 2024 | Giladi Moshe | Chief Science Officer | A | Stock Options (Right to buy) | 78174 | $16.30 | 78,174.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2023 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 128 | $12.69 | 35,323.0000 | 0 | 0.36% | 0.00% |
| Feb. 27, 2024 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 81799 | $16.30 | 117,122.0000 | 0 | 231.57% | 0.00% |
| Feb. 27, 2024 | Ben Arye Barak | General Counsel | A | Stock Options (Right to buy) | 125078 | $16.30 | 125,078.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Cordova Ashley | Chief Financial Officer | A | Stock Options (Right to buy) | 156348 | $16.30 | 156,348.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 3 | $12.69 | 209,828.0000 | 0 | 0.00% | 0.00% |
| Feb. 27, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Stock Options (Right to buy) | 71920 | $16.30 | 71,920.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2303 | $16.14 | 254,559.0000 | 0 | 0.90% | 0.00% |
| Feb. 27, 2024 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 102249 | $16.30 | 219,867.0000 | 0 | 86.93% | 0.00% |
| Feb. 27, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 102249 | $16.30 | 164,695.0000 | 0 | 163.74% | 0.00% |
| Nov. 7, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 382 | $12.65 | 124,511.0000 | 0 | 0.31% | 0.00% |
| Oct. 31, 2023 | Puri Michal Nath | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 57604 | $13.30 | 57,604.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2023 | Puri Michal Nath | Chief Human Resources Officer | A | Ordinary Shares | 37593 | $0.00 | 37,593.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 7561 | $11.46 | 107,211.0000 | 0 | 7.59% | 0.00% |
| Nov. 2, 2023 | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 175 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 7752 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 2480 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 7561 | $0.00 | 175.0000 | 0 | 97.74% | 0.00% |
| Nov. 2, 2023 | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 175 | $11.46 | 117,618.0000 | 0 | 0.15% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 7752 | $7.15 | 117,443.0000 | 0 | 7.07% | 0.00% |
| Oct. 31, 2023 | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 2480 | $11.44 | 109,691.0000 | 0 | 2.31% | 0.00% |
| Sept. 1, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 273 | $21.82 | 124,893.0000 | 0 | 0.22% | 0.00% |
| Sept. 1, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 883 | $21.82 | 99,650.0000 | 0 | 0.88% | 0.00% |
| Sept. 1, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 294 | $21.82 | 209,825.0000 | 0 | 0.14% | 0.00% |
| Aug. 2, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 1144 | $30.25 | 100,533.0000 | 0 | 1.13% | 0.00% |
| June 30, 2023 | Burke William Patrick | Chief Human Resources Officer | A | Ordinary Shares | 357 | $35.28 | 66,447.0000 | 0 | 0.54% | 0.00% |
| June 30, 2023 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 288 | $35.28 | 35,195.0000 | 0 | 0.83% | 0.00% |
| June 30, 2023 | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 367 | $35.28 | 13,989.0000 | 0 | 2.69% | 0.00% |
| June 30, 2023 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 367 | $35.28 | 101,677.0000 | 0 | 0.36% | 0.00% |
| June 30, 2023 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 305 | $35.28 | 89,349.0000 | 0 | 0.34% | 0.00% |
| June 30, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 366 | $35.28 | 210,119.0000 | 0 | 0.17% | 0.00% |
| June 30, 2023 | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 367 | $35.28 | 125,166.0000 | 0 | 0.29% | 0.00% |
| June 7, 2023 | HILLEMAN JERYL L | Not found | A | Stock Option (Right to Buy) | 12554 | $0.00 | 12,554.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | VERNON W ANTHONY | Not found | A | Restricted Stock Units | 3853 | $0.00 | 165,797.0000 | 0 | 2.38% | 0.00% |
| June 7, 2023 | VERNON W ANTHONY | Not found | A | Stock Option (Right to Buy) | 6277 | $0.00 | 6,277.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Scannell Timothy J | Not found | A | Restricted Stock Units | 3853 | $0.00 | 3,928.0000 | 0 | 5137.33% | 0.00% |
| June 7, 2023 | Scannell Timothy J | Not found | A | Stock Option (Right to Buy) | 6277 | $0.00 | 6,277.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Hung David | Not found | A | Stock Option (Right to Buy) | 12554 | $0.00 | 12,554.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Madden Martin J. | Not found | A | Stock Option (Right to Buy) | 12554 | $0.00 | 12,554.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | LEUNG GABRIEL | Not found | A | Restricted Stock Units | 3853 | $0.00 | 79,139.0000 | 0 | 5.12% | 0.00% |
| June 7, 2023 | LEUNG GABRIEL | Not found | A | Stock Option (Right to Buy) | 6277 | $0.00 | 6,277.0000 | 0 | 9999.99% | 0.00% |
| May 9, 2023 | Stafford Kristin | Not found | A | Stock Option (Right to Buy) | 15873 | $0.00 | 15,873.0000 | 0 | 9999.99% | 0.00% |
| May 9, 2023 | Stafford Kristin | Not found | A | Stock Option (Right to Buy) | 15873 | $0.00 | 15,873.0000 | 0 | 9999.99% | 0.00% |
| March 3, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 4403 | $76.16 | 63,490.0000 | 0 | 6.49% | 0.00% |
| March 3, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 888 | $76.16 | 62,602.0000 | 0 | 1.40% | 0.00% |
| March 7, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 6003 | $75.00 | 56,599.0000 | 0 | 9.59% | 0.00% |
| March 7, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2315 | $75.59 | 54,284.0000 | 0 | 4.09% | 0.00% |
| March 3, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 1570 | $76.16 | 144,650.0000 | 0 | 1.07% | 0.00% |
| March 3, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 2942 | $76.16 | 141,708.0000 | 0 | 2.03% | 0.00% |
| March 3, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 16909 | $76.16 | 124,799.0000 | 0 | 11.93% | 0.00% |
| March 3, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 3528 | $76.16 | 231,860.0000 | 0 | 1.50% | 0.00% |
| March 3, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1692 | $76.16 | 230,168.0000 | 0 | 0.73% | 0.00% |
| March 3, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 20415 | $76.16 | 209,753.0000 | 0 | 8.87% | 0.00% |
| March 3, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 4730 | $76.16 | 102,085.0000 | 0 | 4.43% | 0.00% |
| March 3, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 775 | $76.16 | 101,310.0000 | 0 | 0.76% | 0.00% |
| March 3, 2023 | Burke William Patrick | Chief Human Resources Officer | S | Ordinary Shares | 593 | $76.16 | 66,090.0000 | 0 | 0.89% | 0.00% |
| March 3, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2059 | $77.64 | 67,893.0000 | 0 | 2.94% | 0.00% |
| March 3, 2023 | Leonard Frank X | President, CNS Cancers US | A | Ordinary Shares | 11808 | $0.00 | 69,952.0000 | 0 | 20.31% | 0.00% |
| March 3, 2023 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 28830 | $0.00 | 85,108.0000 | 0 | 51.23% | 0.00% |
| March 3, 2023 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 3936 | $0.00 | 89,044.0000 | 0 | 4.62% | 0.00% |
| March 2, 2023 | Burke William Patrick | Chief Human Resources Officer | S | Ordinary Shares | 281 | $75.28 | 66,683.0000 | 0 | 0.42% | 0.00% |
| March 2, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 937 | $75.28 | 99,038.0000 | 0 | 0.94% | 0.00% |
| March 3, 2023 | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 3936 | $0.00 | 102,974.0000 | 0 | 3.97% | 0.00% |
| March 3, 2023 | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 43246 | $0.00 | 146,220.0000 | 0 | 42.00% | 0.00% |
| March 2, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1213 | $75.28 | 183,402.0000 | 0 | 0.66% | 0.00% |
| March 3, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 48050 | $0.00 | 231,452.0000 | 0 | 26.20% | 0.00% |
| March 3, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 3936 | $0.00 | 235,388.0000 | 0 | 1.70% | 0.00% |
| March 2, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 1055 | $75.28 | 95,007.0000 | 0 | 1.10% | 0.00% |
| March 3, 2023 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 11808 | $0.00 | 106,815.0000 | 0 | 12.43% | 0.00% |
| March 2, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 844 | $75.28 | 58,144.0000 | 0 | 1.43% | 0.00% |
| March 2, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 3799 | $75.32 | 59,296.0000 | 0 | 6.02% | 0.00% |
| March 2, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 308 | $76.05 | 58,988.0000 | 0 | 0.52% | 0.00% |
| Feb. 28, 2023 | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 12992 | $0.00 | 56,278.0000 | 0 | 30.01% | 0.00% |
| Feb. 28, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Options to Buy Ordinary Shares | 36013 | $76.97 | 36,013.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2164 | $76.36 | 184,615.0000 | 0 | 1.16% | 0.00% |
| Feb. 28, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 21653 | $0.00 | 186,779.0000 | 0 | 13.11% | 0.00% |
| Feb. 28, 2023 | Burke William Patrick | Chief Human Resources Officer | A | Options to Buy Ordinary Shares | 20168 | $76.97 | 20,168.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Burke William Patrick | Chief Human Resources Officer | S | Ordinary Shares | 755 | $76.36 | 66,964.0000 | 0 | 1.11% | 0.00% |
| Feb. 28, 2023 | Burke William Patrick | Chief Human Resources Officer | A | Ordinary Shares | 12125 | $0.00 | 67,719.0000 | 0 | 21.81% | 0.00% |
| Feb. 28, 2023 | Cordova Ashley | Chief Financial Officer | A | Options to Buy Ordinary Shares | 39614 | $76.97 | 39,614.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 2198 | $76.36 | 96,062.0000 | 0 | 2.24% | 0.00% |
| Feb. 28, 2023 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 23818 | $0.00 | 98,260.0000 | 0 | 32.00% | 0.00% |
| Feb. 28, 2023 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 29531 | $76.97 | 29,531.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 17755 | $0.00 | 34,907.0000 | 0 | 103.52% | 0.00% |
| Feb. 28, 2023 | Weinberg Uri | Chief Innovation Officer | A | Options to Buy Ordinary Shares | 21607 | $76.97 | 21,607.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Shah Pritesh | Chief Growth Officer | A | Options to Buy Ordinary Shares | 31691 | $76.97 | 31,691.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 1923 | $76.36 | 99,975.0000 | 0 | 1.89% | 0.00% |
| Feb. 28, 2023 | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 19055 | $0.00 | 101,898.0000 | 0 | 23.00% | 0.00% |
| Feb. 28, 2023 | Leonard Frank X | President, CNS Cancers US | A | Options to Buy Ordinary Shares | 30971 | $76.97 | 30,971.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 1684 | $76.36 | 63,095.0000 | 0 | 2.60% | 0.00% |
| Feb. 28, 2023 | Leonard Frank X | President, CNS Cancers US | A | Ordinary Shares | 18621 | $0.00 | 64,779.0000 | 0 | 40.34% | 0.00% |
| Jan. 6, 2023 | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 102 | $62.31 | 165,126.0000 | 0 | 0.06% | 0.00% |
| Jan. 6, 2023 | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 66 | $62.31 | 74,442.0000 | 0 | 0.09% | 0.00% |
| Jan. 6, 2023 | Ben Arye Barak | General Counsel | A | Ordinary Shares | 150 | $62.31 | 17,152.0000 | 0 | 0.88% | 0.00% |
| Jan. 6, 2023 | Burke William Patrick | Chief Human Resources Officer | A | Ordinary Shares | 108 | $62.31 | 55,594.0000 | 0 | 0.19% | 0.00% |
| Jan. 6, 2023 | Benaim Ely | Chief Medical Officer | A | Ordinary Shares | 98 | $62.31 | 28,770.0000 | 0 | 0.34% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 1395 | $116.06 | 18,549.0000 | 0 | 6.99% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 3702 | $115.21 | 19,944.0000 | 0 | 15.66% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 4568 | $114.35 | 23,646.0000 | 0 | 16.19% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 2000 | $112.86 | 28,214.0000 | 0 | 6.62% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 8369 | $111.23 | 30,214.0000 | 0 | 21.69% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7826 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | M | Ordinary Shares | 25000 | $11.46 | 38,583.0000 | 0 | 184.05% | 0.00% |
| Jan. 5, 2023 | Shah Pritesh | Chief Commercial Officer | S | Ordinary Shares | 387 | $108.00 | 82,843.0000 | 0 | 0.46% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7183 | $0.00 | 17,662.0000 | 0 | 28.91% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7183 | $0.00 | 10,479.0000 | 0 | 40.67% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 5517 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7826 | $108.00 | 46,158.0000 | 0 | 14.50% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7500 | $11.46 | 53,658.0000 | 0 | 16.25% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7500 | $108.00 | 46,158.0000 | 0 | 13.98% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 5517 | $7.15 | 51,675.0000 | 0 | 11.95% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 5517 | $108.00 | 46,158.0000 | 0 | 10.68% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7183 | $21.15 | 53,341.0000 | 0 | 15.56% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7183 | $114.00 | 46,158.0000 | 0 | 13.47% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7183 | $21.15 | 53,341.0000 | 0 | 15.56% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7183 | $120.00 | 46,158.0000 | 0 | 13.47% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | M | Options to Buy Ordinary Shares | 187500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | M | Options to Buy Ordinary Shares | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7826 | $14.37 | 53,984.0000 | 0 | 16.95% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 1010 | $117.00 | 46,158.0000 | 0 | 2.14% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 526 | $115.03 | 47,168.0000 | 0 | 1.10% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 417 | $108.00 | 47,694.0000 | 0 | 0.87% | 0.00% |
| Jan. 5, 2023 | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2345 | $119.01 | 48,111.0000 | 0 | 4.65% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | M | Options to Buy Ordinary Shares | 1946 | $0.00 | 1,946.0000 | 0 | 50.00% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 1201 | $120.00 | 43,286.0000 | 0 | 2.70% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 2617 | $108.00 | 44,487.0000 | 0 | 5.56% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 1946 | $120.00 | 47,104.0000 | 0 | 3.97% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | M | Ordinary Shares | 1946 | $47.04 | 49,050.0000 | 0 | 4.13% | 0.00% |
| Jan. 5, 2023 | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 2379 | $120.00 | 47,104.0000 | 0 | 4.81% | 0.00% |
| Jan. 6, 2023 | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 39 | $62.31 | 13,622.0000 | 0 | 0.29% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | M | Ordinary Shares | 187500 | $7.15 | 201,083.0000 | 0 | 1380.40% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 187500 | $108.00 | 13,583.0000 | 0 | 93.25% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 500 | $119.99 | 13,583.0000 | 0 | 3.55% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 1344 | $119.35 | 14,083.0000 | 0 | 8.71% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 2123 | $118.47 | 15,427.0000 | 0 | 12.10% | 0.00% |
| Jan. 5, 2023 | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 999 | $117.01 | 17,550.0000 | 0 | 5.39% | 0.00% |